The Approval of New Drugs Should Be Harmonized Across the Nordic Countries

At the Nordic Breast Cancer Network Conference in Copenhagen in December 2024, Minna Tanner, Chair of the Finnish Breast Cancer Group, addressed the national approval of new breast cancer drugs. In this MEDtalk, she argues that oncologists should collaborate in assessing the use of new drugs and emphasizes the value of harmonizing drug approvals across the Nordic countries.